Skip to main content

ETHNOS_APP

Home • Search • Journals • List 0

Johannes C S Zang

Biographic Data

ID7370156
NAMEJohannes C S Zang
GIVEN NAMESJohannes C S
FAMILY NAMEZang
SIGNATUREZANG J C S
AFFILIATIONSHeidelberg University
ORCID0000-0001-5046-1911
VERIFIEDYes
TOTAL WORKS4
TOTAL CITATIONS0
WORKS AS AUTHOR4
WORKS AS EDITOR0
FIRST PUBLICATION YEAR2023
LATEST PUBLICATION YEAR2025
H-INDEX0
  • Factors influencing patient decision-making on a multimodal precision medicine algorithm for depression

    Open Access•Rosa Glaser, Johannes C S Zang et al.•ARTICLE•Frontiers in Psychiatry•2025

    While patients are open to the use of a multimodal precision medicine algorithm for MDD, they emphasised the need for individualised, transparent communication and emotional support. The results highlight the importance of patient-centred communication strategies and guidelines for the ethical implementation of precision psychiatry

  • Attitudes towards a multimodal precision medicine algorithm for predicting treatment response in depression

    Open Access•Viktor T H Wahner, Johannes C S Zang et al.•ARTICLE•Frontiers in Psychiatry•2025

    Overall, participants indicated a large degree of acceptance towards the application of a multimodal precision medicine algorithm. Although limited by the hypothetical nature of the decision scenario, this study provides valuable perspectives from different stakeholders. Future research should move beyond attitudes and address further implementation hurdles that need to be overcome for the successful implementation of novel precision psychiatry a…

  • An integrated precision medicine approach in major depressive disorder

    Open Access•Bernhard T Baune, Alessandra Minelli et al.•ARTICLE•Frontiers in Psychiatry•2024

    Major depressive disorder (MDD) is the most common psychiatric disease worldwide with a huge socio-economic impact. Pharmacotherapy represents the most common option among the first-line treatment choice; however, only about one third of patients respond to the first trial and about 30% are classified as treatment-resistant depression (TRD). TRD is associated with specific clinical features and genetic/gene expression signatures. To date, single …

  • Treatment-associated mRNA co-expression changes in monocytes of patients with posttraumatic stress disorder

    Open Access•Robert Kumsta, Johannes C S Zang et al.•ARTICLE•Frontiers in Psychiatry•2023

    PTSD is a prevalent mental disorder that results from exposure to extreme and stressful life events and comes at high costs for both the individual and society. Therapeutic treatment presents the best way to deal with PTSD-the mechanisms underlying change after treatment, however, remain poorly understood. While stress and immune associated gene expression changes have been associated with PTSD development, studies investigating treatment effects…

No prominent works on this page.

  • Treatment-associated mRNA co-expression changes in monocytes of patients with posttraumatic stress disorder

    Open Access•Robert Kumsta, Johannes C S Zang et al.•ARTICLE•Frontiers in Psychiatry•2023

    PTSD is a prevalent mental disorder that results from exposure to extreme and stressful life events and comes at high costs for both the individual and society. Therapeutic treatment presents the best way to deal with PTSD-the mechanisms underlying change after treatment, however, remain poorly understood. While stress and immune associated gene expression changes have been associated with PTSD development, studies investigating treatment effects…

  • An integrated precision medicine approach in major depressive disorder

    Open Access•Bernhard T Baune, Alessandra Minelli et al.•ARTICLE•Frontiers in Psychiatry•2024

    Major depressive disorder (MDD) is the most common psychiatric disease worldwide with a huge socio-economic impact. Pharmacotherapy represents the most common option among the first-line treatment choice; however, only about one third of patients respond to the first trial and about 30% are classified as treatment-resistant depression (TRD). TRD is associated with specific clinical features and genetic/gene expression signatures. To date, single …

  • Factors influencing patient decision-making on a multimodal precision medicine algorithm for depression

    Open Access•Rosa Glaser, Johannes C S Zang et al.•ARTICLE•Frontiers in Psychiatry•2025

    While patients are open to the use of a multimodal precision medicine algorithm for MDD, they emphasised the need for individualised, transparent communication and emotional support. The results highlight the importance of patient-centred communication strategies and guidelines for the ethical implementation of precision psychiatry

  • Attitudes towards a multimodal precision medicine algorithm for predicting treatment response in depression

    Open Access•Viktor T H Wahner, Johannes C S Zang et al.•ARTICLE•Frontiers in Psychiatry•2025

    Overall, participants indicated a large degree of acceptance towards the application of a multimodal precision medicine algorithm. Although limited by the hypothetical nature of the decision scenario, this study provides valuable perspectives from different stakeholders. Future research should move beyond attitudes and address further implementation hurdles that need to be overcome for the successful implementation of novel precision psychiatry a…

Precision medicine (3 works) · Bioinformatics (2 works) · Biology (2 works) · Digital Mental Health Interventions (2 works) · Internal Medicine (2 works) · Medicine (2 works) · MEDLINE (2 works) · Mental Health Treatment and Access (2 works) · Personalized medicine (2 works) · Psychiatry (2 works)

Ethnos_APP • Open Source Project • MIT License • Frontend v2.0.0 • Privacy and Cookies • API Documentation: api.ethnos.app/docs • API Source Code: GitHub • DOI: 10.5281/zenodo.17049435 • Frontend Source Code: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae